THREATENED ABORTION: CLINICAL COURSE, PROGNOSIS, AND MANAGEMENT APPROACHES

This article explores the real-world experiences and clinical outcomes of women facing threatened abortion during early pregnancy—a condition that causes not only physical concern but also emotional stress for expectant mothers. Threatened abortion is typically marked by vaginal bleeding before the 20th week of gestation, yet the pregnancy remains viable with the cervix still closed. Although many cases resolve without serious consequences, others may progress to miscarriage if not carefully monitored and treated. This study was carried out at the Multidisciplinary Clinic of Samarkand State Medical University between 2023 and 2024, involving 112 women who presented with symptoms such as spotting, lower abdominal discomfort, and uterine tension. By evaluating clinical signs, ultrasound findings, and hormonal levels—particularly progesterone—we aimed to better understand which factors influence pregnancy outcomes. Most women (68%) had mild symptoms and responded well to supportive outpatient care, including hormone therapy—however, nearly a third experienced more serious signs requiring hospitalisation and closer monitoring. Notably, women with lower progesterone levels were more likely to experience pregnancy loss, highlighting the hormone’s vital role in early gestation. This study underscores the importance of timely diagnosis, compassionate care, and targeted treatment to protect both mother and child. It also calls for improved awareness and standardized care protocols in Uzbekistan to better support women at risk of early pregnancy complications. Keywords: Threatened abortion, early pregnancy bleeding, progesterone levels, miscarriage risk, maternal health, prenatal care